一致Ｂ：2018年年度报告（英文版）.PDF

1、1China National Accord Medicines Corporation Ltd.Annual Report 2018April 20191Section I.Important Notice,Contents and ParaphraseBoard of Directors,Supervisory Committee,all directors,supervisors and seniorexecutives of China National Accord Medicines Corporation Ltd.(hereinafterreferred to as the Co

2、mpany)hereby confirm that there are no any fictitiousstatements,misleading statements,or important omissions carried in this report,and shall take all responsibilities,individual and/or joint,for the reality,accuracy and completion of the whole contents.Lin Zhaoxiong,Principal of the Company,Wei Pin

3、gxiao,person in charger ofaccounting works and Wang Ying,person in charge of accounting organ(accounting principal)hereby confirm that the Financial Report of 2018 AnnualReport is authentic,accurate and complete.Other directors attending the Meeting for annual report deliberation except forthe follo

4、wedName of director absentTitle for absent directorReasons for absentAttorneyLi ZhimingdirectorOfficial businessLiu YongJiang XiuchangdirectorOfficial businessLiu YongAffected by various risk factors,the companys business operations are facingrisks in terms of changes in industry policies and intens

5、ified market competition.The company has made a specific statement on the“Future DevelopmentProspects”of the fourth section“Discussion and Analysis of the Operation”inthis annual report,and all investors should pay attention to it.The profit distribution plan that deliberated and approved by the Boa

6、rd is:based on total stock issued 428,126,983 shares,distributed 4.00 Yuan(taxincluded)bonus in cash for every 10-share hold by all shareholders,0 sharesbonus issued(tax included)and no capitalizing of common reserves carried out.2ContentsSection I Important Notice,Contents and Paraphrase.1Section I